Medexus Pharmaceuticals Archives

Press ESC key to close search

BMO Provides $35MM Term Loan to Medexus Pharmaceuticals

Medexus Pharmaceuticals entered into a senior secured credit agreement agented by BMO. The credit agreement provides for a $35 million term loan facility and a $3.5 million revolving loan facility for working capital.

MidCap Increases Revolving Loan Commitment by $5MM for Medexus

As part of an amendment to Medexus Pharmaceuticals’ revolving credit facility, MidCap Funding IV Trust increased its loan commitment by $5 million, bringing the total facility’s capacity to $25 million.

September 30, 2022 Marcel Konrad | Medexus Pharmaceuticals | MidCap Funding IV Trust Phil Neuffer

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: Medexus Pharmaceuticals

BMO Provides $35MM Term Loan to Medexus Pharmaceuticals

MidCap Increases Revolving Loan Commitment by $5MM for Medexus